scorecardresearchNatco Pharma Share Price Live NSE, BSE, Today - Natco Pharma Stock Price

Natco Pharma

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | SECTOR: Biotechnology & Drugs

992.00 10.50 (1.07%)

02 Mar 2024, 06:59 (IST)
  • Open

    1,010.00
  • High

    1,010.00
  • Low

    985.05
  • Prev Close

    981.50
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    177.68B
  • Volume

    0.55K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    991.00
  • Ask

    992.00

Company Description

  • Biotechnology & Drugs
  • BSE

    524816
  • NSE

    NATCOPHARM
  • ISIN

    INE987B01026

Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. The Company deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The Company operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.

Company Officers

  • Rajeev Nannapaneni

    Chief Executive Officer, Executive Director
  • S. V. V. N. Appa Rao

    Chief Financial Officer
  • Lingarao Donthineni

    President - Technical Affairs, Executive Director
  • Pavan Bhat

    Executive Vice President - Technical Operations, Executive Director
  • Potluri Prasad

    Executive Vice President - Corporate Engineering Services, Executive Director
  • Rajesh Chebiyam

    Executive Vice President - Crop Health Sciences
  • Ramesh Dandala

    Executive Vice President - Technology Transfer, Intellectual Property Rights and Regulatory Affairs (API)
  • M. Pullam Reddy

    Executive Vice President - R&D
  • Srinivas C. H.

    Senior Vice President - Demand and Supply Planning
  • Sunil Kotaru

    Senior Vice President - Supply Chain Management